Stoke Therapeutics News and Activities

Presence

Stoke Therapeutics develops RNA-based medicines for genetic diseases. Its products and research services focus on experimental therapies and drug discovery for patients, healthcare providers, and research partners.

Stoke Therapeutics products and services overview:

RNA medicines
Genetic disease therapies
Drug discovery
Clinical development
Research partnerships

Revenue: ~$18 million

Employees: 180

Headquarters: Bedford, United States (USA)

Stoke Therapeutics is one of the...

Stoke Therapeutics is a company listed under the stock ticker STOK (US).

Executives

View the org chart displaying its 40 main executives

Most searched biographies at Stoke Therapeutics

Popular executive movements at Stoke Therapeutics

Thomas Mccauley has joined the company as Chief Scientific Officer (posted on July 13 2026).
Alice Wyse Jackson, who was Senior Director, Medical Affairs, is promoted to Executive Director, Scientific Communications and Information (posted on July 13 2026).
Nathan Lee has joined the company as Vice President, Commercial Manufacturing (posted on May 26 2026).

Click here to view some more movements at Stoke Therapeutics

Create your alert
to follow the executive moves at Stoke Therapeutics.